Pharma Plans for Brexit
While the threat of a no-deal Brexit grows and tension mounts, the world of UK pharma is continuing to develop their contingency plans.
29th June 2018
Healthcare marketing communications and PR agency, Onyx Health has announced plans to expand across the North of England following the success it’s had of generating growth for clients in the North East.
Onyx Health is passionate about helping healthcare companies achieve commercial success by delivering innovative marketing campaigns and developing sales strategies, driven by their unique market knowledge and insight.
Karen Winterhalter, Director at Onyx Health believes that strategic marketing communications is the key to turnover and growth, especially when today’s healthcare market is much more complex and challenging to enter.
Karen says: “We work alongside clients to understand what they need to say and who they need to say it to, helping them to overcome market barriers and generate sales. The strategies we recommend is based on our healthcare knowledge and understanding, allowing us to deliver exceptional and impactful campaigns.”
The company already has several clients such as Zilico based in the North West, but wanting to make it easier for other diagnostic, medical technology, biomedical and life science companies to connect with them, they have joined Bionow which supports growth, competitiveness and innovation within the biomedical and life science sectors across Northern England.
As an introductory step, the team look forward to meeting Bionow members at the 2018 BioFocus Conference on Tuesday 3rd July, in Newcastle, where they will be attending as gold exhibitors.
The life sciences sector in the UK consists of over 4,500 businesses of which more than 1000 are in the North, employing 38,000 people with a turnover of £10.9 billion – and therefore is a crucial part of the UK’s post-Brexit economy.